Display options
Share it on

Bio Protoc. 2019 Oct 20;9(20):e3404. doi: 10.21769/BioProtoc.3404. eCollection 2019 Oct 20.

Quantification of HIV-2 DNA in Whole Blood.

Bio-protocol

Zsófia Szojka, Sara Karlson, Marianne Jansson, Patrik Medstrand

Affiliations

  1. Department of Translational Medicine, Clinical Virology, Lund University, Malmö, Sweden.
  2. Laboratory of Retroviral Biochemistry, Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  3. Department of Laboratory Medicine, Lund University, Lund, Sweden.

PMID: 33654905 PMCID: PMC7853964 DOI: 10.21769/BioProtoc.3404

Abstract

Time to AIDS infection is longer with HIV-2, compared to HIV-1, but without antiretroviral therapy both infections will cause AIDS-related mortality. In HIV-2 infection, monitoring of antiretroviral treatment (ART) efficacy is challenging since a large proportion of HIV-2-infected individuals displays low or undetectable plasma RNA levels. Hence, quantification of cellular DNA load may constitute an alternative method for monitoring ART efficacy. Moreover, sensitive HIV-2 DNA quantification protocols are also important for the characterization of the HIV-2 reservoirs, and ultimately for the development of HIV-2 cure strategies. We have developed a sensitive and robust HIV-2 DNA quantification protocol based on whole blood as DNA source, including normalization of leukocyte cell numbers using parallel quantification of the single copy porphobilinogen deaminase gene. The specificity and sensitivity of the assay was 100%. The limit of detection was 1 copy and limit of quantification was 5 copies. When applying this protocol to HIV-2 infected, it was found that HIV-2 viral DNA was detectable in individuals in whom viral RNA was undetectable or under quantification level. Thus, this method provides a sensitive approach to HIV-2 DNA viral quantification from whole blood of HIV-2 infected patients.

Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Keywords: DNA load; HIV-2; Quantification; Whole Blood; qPCR

Conflict of interest statement

Competing interestsThe funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors have no conflict of interest.

References

  1. AIDS. 2008 Jan 11;22(2):211-5 - PubMed
  2. Lancet HIV. 2018 Nov 1;: - PubMed
  3. J Infect Dis. 1999 Oct;180(4):1116-21 - PubMed
  4. J Infect Dis. 1996 Jan;173(1):245-8 - PubMed
  5. Nucleic Acids Res. 2004 Feb 11;32(3):e24 - PubMed
  6. J Clin Microbiol. 2001 Dec;39(12):4264-8 - PubMed
  7. J Clin Microbiol. 1999 Feb;37(2):453-6 - PubMed
  8. J Clin Microbiol. 2012 Feb;50(2):258-63 - PubMed
  9. Retrovirology. 2018 Apr 3;15(1):30 - PubMed
  10. J Clin Microbiol. 2002 Oct;40(10):3654-9 - PubMed
  11. AIDS Rev. 2016 Jan-Mar;18(1):44-53 - PubMed
  12. J Hum Virol. 1998 Nov-Dec;1(7):457-68 - PubMed
  13. J Virol. 2006 Dec;80(24):12425-9 - PubMed
  14. AIDS. 2016 Oct 23;30(16):2415-2426 - PubMed
  15. Arch Intern Med. 2000 Nov 27;160(21):3286-93 - PubMed
  16. J Clin Microbiol. 2017 Sep;55(9):2850-2857 - PubMed
  17. Science. 1987 Nov 6;238(4828):800-2 - PubMed
  18. J Virol. 1995 Jun;69(6):3712-20 - PubMed
  19. J Virol. 2000 Feb;74(3):1554-7 - PubMed
  20. HIV Med. 2018 Jul;19(6):403-410 - PubMed
  21. Nucleic Acids Res. 1986 Aug 11;14(15):5955-68 - PubMed
  22. Methods Mol Biol. 2009;485:55-72 - PubMed

Publication Types